Go-ahead for trials of electric drug delivery:
This article was originally published in Clinica
Executive Summary
Trials of a device which uses electric fields to open pores in cells to deliver cancer drugs are to begin in Canada. The Phase II study will assess Genetronics Biomedical's MedPulser device as a way of delivering the drug Bleomycin in the treatment of advance head and neck tumours. Some 25 patients will be studied at four sites throughout Canada. Phase II trials have already begun in the US and the company said the preliminary data show that very low doses of the drug are effective.